Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
18.13
+0.33 (1.85%)
At close: Jun 26, 2026, 4:00 PM EDT
18.06
-0.07 (-0.39%)
After-hours: Jun 26, 2026, 4:10 PM EDT

Odyssey Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
865----
Enterprise Value
715----
Debt / Equity Ratio
0.140.130.230.150.17
Net Debt / Equity Ratio
-0.83-0.88-0.74-0.81-0.81
Net Debt / EBITDA Ratio
1.031.260.761.411.67
Net Debt / FCF Ratio
1.131.450.831.541.77
Asset Turnover
-0.010.020.00-
Quick Ratio
7.916.854.558.4710.57
Current Ratio
8.337.204.778.7210.91
Return on Equity (ROE)
--85.50%-72.26%-53.29%-
Return on Assets (ROA)
--41.66%-34.93%-27.63%-
Return on Capital Employed (ROCE)
-72.80%-64.00%-80.00%-50.50%-41.60%
Buyback Yield / Dilution
-538.14%-267.45%-24.54%-44.71%-
SEC Filings: 10-K · 10-Q